| Date Filed | Type | Description |
| 08/11/2023 |
SC 13G
| INTRACOASTAL CAPITAL, LLC reports a 7.1% stake in INVO Bioscience, Inc. |
| 08/10/2023 |
SC 13G
| INTRACOASTAL CAPITAL, LLC reports a 7.6% stake in Adamis Pharmaceuticals Corporation |
| 07/14/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 06/30/2023 |
SC 13G
| INTRACOASTAL CAPITAL, LLC reports a 4.2% stake in Innovative Eyewear, Inc. |
| 06/01/2023 |
SC 13G
| INTRACOASTAL CAPITAL, LLC reports a 5% stake in Dermata Therapeutics, Inc. |
| 05/25/2023 |
SC 13G
| INTRACOASTAL CAPITAL, LLC reports a 5% stake in OncoSec Medical Incorporated |
| 04/28/2023 |
SC 13G
| INTRACOASTAL CAPITAL, LLC reports a 4.2% stake in Allarity Therapeutics, Inc. |
| 04/19/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 04/14/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/24/2023 |
SC 13G
| INTRACOASTAL CAPITAL, LLC reports a 0% stake in Atlis Motor Vehicles Inc. |
| 02/23/2023 |
SC 13G
| INTRACOASTAL CAPITAL, LLC reports a 5% stake in TOP Ships Inc. |
| 02/13/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/08/2023 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 2.7% stake in Pulmatrix, Inc. |
| 02/08/2023 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 1.2% stake in ToughBuilt Industries, Inc. |
| 02/08/2023 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 6.2% stake in Performance Shipping Inc. |
| 02/08/2023 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 9.6% stake in TIAN RUIXIANG Holdings Ltd |
| 02/08/2023 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 7.6% stake in Petros Pharmaceuticals, Inc. |
| 02/08/2023 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 8.7% stake in Globus Maritime Limited |
| 02/08/2023 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 5.6% stake in Phio Pharmaceuticals Corp. |
| 02/08/2023 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 5.3% stake in Histogen Inc. |
| 02/08/2023 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 9% stake in Kiora Pharmaceuticals, Inc. |
| 02/08/2023 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 4.2% stake in Hoth Therapeutics, Inc. |
| 02/08/2023 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 6.3% stake in Agile Therapeutics, Inc. |
| 02/08/2023 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 5.1% stake in Helius Medical Technologies, Inc. |
| 02/08/2023 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 9.4% stake in Enveric Biosciences, Inc. |
| 02/08/2023 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 5.1% stake in Baudax Bio, Inc. |
| 02/08/2023 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 7.5% stake in Guardion Health Sciences, Inc. |
| 02/08/2023 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 10% stake in Synaptogenix, Inc. |
| 02/08/2023 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 10% stake in PharmaCyte Biotech, Inc. |
| 02/08/2023 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 10% stake in Antelope Enterprise Holdings Limited |
| 02/08/2023 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 5.7% stake in Palisade Bio, Inc. |
| 02/08/2023 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 5.8% stake in Aditxt, Inc. |
| 12/09/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/17/2022 |
SC 13G
| INTRACOASTAL CAPITAL, LLC reports a 5% stake in Avenue Therapeutics, Inc. |
|